Literature DB >> 26177495

Obesity and inflammatory biomarkers in women with polycystic ovary syndrome.

Szu-Hung Shen1, Szu-Yu Shen1, Tsan-Hon Liou2, Ming-I Hsu3, Yuan-chin Ivan Chang4, Chih-Yu Cheng5, Chun-Sen Hsu1, Chii-Ruey Tzeng6.   

Abstract

OBJECTIVE: To evaluate the roles of obesity and inflammatory biomarkers associated with medical complications in women with PCOS. STUDY
DESIGN: Retrospective, BMI-matched study. A total of 330 patients, including 165 women with PCOS and 165 women without PCOS, were evaluated. The insulin resistance (homeostasis model assessment insulin resistance index - HOMA) and lipid profiles were assessed. The adiponectin, leptin, ghrelin, resistin, anti-müllerian hormone (AMH), sex hormone-binding globulin (SHBG), high sensitivity C-reactive protein (hs-CRP), and interleukin-6 (IL-6) levels were also measured.
RESULTS: Women with PCOS had significantly higher AMH, fasting insulin, total cholesterol, and low-density lipoprotein levels and lower SHBG levels compared with the controls. There was no difference in the serum obesity and inflammatory biomarkers between the PCOS cases and the controls. After adjusting for BMI and age, IL-6 was positively correlated with HOMA, and SHBG was negatively correlated with HOMA, triglyceride, and LDL.
CONCLUSIONS: The serum adipokines levels are not good markers for PCOS. PCOS patients were characterized by their high AMH and low SHBG levels. A low level of SHBG should play an important role in the pathogenesis of the medical complications observed in women with PCOS. Clinical trial registration number NCT01989039.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adiponectin; Inflammation; Leptin; Obesity; PCOS; Resistin

Mesh:

Substances:

Year:  2015        PMID: 26177495     DOI: 10.1016/j.ejogrb.2015.06.022

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  11 in total

1.  Relationship between obesity and anti-Müllerian hormone in reproductive-aged African American women.

Authors:  Lia A Bernardi; Mercedes R Carnethon; Peter J de Chavez; Deborah E Ikhena; Lisa M Neff; Donna D Baird; Erica E Marsh
Journal:  Obesity (Silver Spring)       Date:  2016-12-07       Impact factor: 5.002

2.  Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.

Authors:  Margaret C Garin; Samantha F Butts; David B Sarwer; Kelly C Allison; Suneeta Senapati; Anuja Dokras
Journal:  Endocrine       Date:  2016-12-21       Impact factor: 3.633

3.  Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.

Authors:  Patricia D A Lima; Anne-Laure Nivet; Qi Wang; Yi-An Chen; Arthur Leader; Annie Cheung; Chii-Ruey Tzeng; Benjamin K Tsang
Journal:  Biol Reprod       Date:  2018-10-01       Impact factor: 4.285

4.  Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial.

Authors:  M Amiri; M Rahmati; M Hedayati; F Nahidi; F Ramezani Tehrani
Journal:  J Endocrinol Invest       Date:  2020-07-17       Impact factor: 4.256

5.  Clomiphene Citrate Treatment Cycle Outcomes of Polycystic Ovary Syndrome Patients Based on Basal High Sensitive C-Reactive Protein Levels: A Cross-Sectional Study.

Authors:  Serkan Kahyaoglu; Omer Hamid Yumuşak; Sebnem Ozyer; Meryem Kuru Pekcan; Merve Erel; Mahmut Nedim Cicek; Salim Erkaya; Yasemin Tasci
Journal:  Int J Fertil Steril       Date:  2016-11-01

6.  Association Between Vitamin D and Adrenal Parameters with Metabolic and Inflammatory Markers in Polycystic Ovary Syndrome.

Authors:  P Maidana; A Fritzler; Y Mocarbel; M B Perez Lana; D González; M Rosales; F González de Chazal; K Sternberg; E Lamas Majek; S Mallea-Gil; E Genovesi; M Pelayo; B Fabre; V Mesch
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

7.  Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis.

Authors:  Tahereh Raeisi; Hossein Rezaie; Mina Darand; Akram Taheri; Nazila Garousi; Bahman Razi; Leonardo Roever; Reza Mohseni; Shimels Hussien Mohammed; Shahab Alizadeh
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

8.  The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis.

Authors:  Shaimaa Aboeldalyl; Cathryn James; Emaduldin Seyam; Emad Moussa Ibrahim; Hossam El-Din Shawki; Saad Amer
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

9.  A Predictive Model of Live Birth Based on Obesity and Metabolic Parameters in Patients With PCOS Undergoing Frozen-Thawed Embryo Transfer.

Authors:  Xiaohua Jiang; Ruijun Liu; Ting Liao; Ye He; Caihua Li; Peipei Guo; Ping Zhou; Yunxia Cao; Zhaolian Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-12       Impact factor: 5.555

Review 10.  Developing a deeper insight into reproductive biomarkers.

Authors:  Braira Wahid; Hamid Bashir; Muhammad Bilal; Khansa Wahid; Aleena Sumrin
Journal:  Clin Exp Reprod Med       Date:  2017-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.